Correlation Between Lipocine and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lipocine and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Tscan Therapeutics, you can compare the effects of market volatilities on Lipocine and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Tscan Therapeutics.
Diversification Opportunities for Lipocine and Tscan Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lipocine and Tscan is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Lipocine i.e., Lipocine and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Lipocine and Tscan Therapeutics
Given the investment horizon of 90 days Lipocine is expected to generate 1.18 times more return on investment than Tscan Therapeutics. However, Lipocine is 1.18 times more volatile than Tscan Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 555.00 in Lipocine on August 27, 2024 and sell it today you would lose (40.00) from holding Lipocine or give up 7.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lipocine vs. Tscan Therapeutics
Performance |
| Timeline |
| Lipocine |
| Tscan Therapeutics |
Lipocine and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipocine and Tscan Therapeutics
The main advantage of trading using opposite Lipocine and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |